Randomized Study of Pessary Versus Standard Management in Women With Increased Chance of Premature Birth
Primary Purpose
Preterm Birth
Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Vaginal pessary (CE0482, MED/CERT ISO 9003 / EN 46003)
Sponsored by

About this trial
This is an interventional prevention trial for Preterm Birth focused on measuring Twins, Short cervix, Preterm birth, Vaginal pessary
Eligibility Criteria
Inclusion Criteria:
- Women with singleton pregnancies and with a cervical length of 25 mm or less
- Women with twin pregnancies
Exclusion Criteria:
- Major fetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery), fetal death, severe twin to twin transfusion syndrome or severe fetal growth restriction in one of the fetuses (in the case of twin pregnancy) diagnosed before randomization.
- Painful regular uterine contractions, history of ruptured membranes, or prophylactic cerclage before randomization.
- Patients who are unconscious, severely ill, mentally handicapped or under the age of 16 years.
Sites / Locations
- Medical University of Vienna-department of Obstetrics and Gynaecology
- Universidade Federal Fluminense - Hospital Universitário Antônio Pedro
- University of Campinas
- Hospital Clinico Universidad de Chile
- Hospital San Jose
- Hospital Universitario San Vicente de Paúl
- Virchow Clinic Charite
- Chinese University of Hong Kong
- Fernandez Hospital, Bogulkunta,
- Ospedale Valduce
- Maternidade Dr. Alfredo da Costa
- Hospital San Teotonio
- University Medical Centre Ljubljana
- Hospital Universitario Materno Infantil de Canarias
- Hospital Universitario Virgen de las Nieves
- Virgen de La Arrixaca
- Heatherwood and Wexham Park Hospitals, Wexham Park Hospital
- Barking, Havering and Redbridge Hospitals NHS Trust
- Southend Hospital NHS Trust
- The Medway Maritime Hospital NHS Trust
- University College London Hospitals NHS Foundation Trust
- The Lewisham Hospital NHS Trust
- Queen Elizabeth Hospital NHS Trust
- King's College Hospital NHS Trust
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
No Intervention
Experimental
No Intervention
Experimental
Arm Label
A
B
C
D
Arm Description
Expectant management in twin pregnancy
Vaginal pessary treatment in twin pregnancy
Expectant management in singleton pregnancy with short cervix; Women with cervix <15 mm will be commenced on vaginal progesterone
Vaginal pessary treatment in singleton pregnancy with short cervix; Women with cervix <15 mm will be commenced on vaginal progesterone
Outcomes
Primary Outcome Measures
The primary outcome measure will be spontaneous delivery from randomization to 33 weeks and 6 days (237 days) of gestation.
Secondary Outcome Measures
Low birth weight; Fetal or neonatal death; Major adverse outcomes (IVH, RDS, retinopathy of prematurity or necrotizing enterocolitis); Need for neonatal special care (ventilation, phototherapy, treatment for sepsis, blood transfusion)
Full Information
NCT ID
NCT00735137
First Posted
August 13, 2008
Last Updated
February 10, 2021
Sponsor
King's College Hospital NHS Trust
1. Study Identification
Unique Protocol Identification Number
NCT00735137
Brief Title
Randomized Study of Pessary Versus Standard Management in Women With Increased Chance of Premature Birth
Official Title
Randomized Study of Pessary vs Standard Management in Women With Increased Chance of Premature Birth
Study Type
Interventional
2. Study Status
Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
August 2008 (undefined)
Primary Completion Date
February 2012 (Actual)
Study Completion Date
February 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
King's College Hospital NHS Trust
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of the study is to determine the effect of cerclage pessary on the incidence of spontaneous delivery between randomization (at 20-24+6 weeks) and 33+6 weeks in asymptomatic women with singleton pregnancies found at routine mid-trimester screening to have a cervix of <25 mm in length and in twin pregnancies.
Detailed Description
Prematurity is responsible for more than half of all neonatal deaths and whilst advances in neonatal care have dramatically improved survival of extremely premature infants, there remains a significant risk of handicap and disability in survivors and an associated social and economic burden.
In singleton pregnancies the rate of spontaneous premature birth before 34 weeks is about 1% and the risk of spontaneous early delivery is inversely related to cervical length. The group with cervix of 1-15 mm accounted for 28% of all spontaneous deliveries before 34 weeks and those with cervix of 16-25 mm accounted for 21%. The rate of spontaneous premature birth before 34 weeks is about 13% in twin pregnancies.
Potential methods for the prevention of preterm delivery include bed rest, cervical cerclage and prophylactic administration of progesterone. The prophylactic administration of progesterone beginning in mid-gestation to women who previously had a premature birth and in those with a short cervix has been shown to reduce the rate of spontaneous preterm birth before 34 weeks. On the other hand, randomized studies reported that, in twin pregnancies, bed rest was associated with a significant increase, rather than decrease, in the rate of early preterm delivery.
There is some evidence that the rate of premature birth can be dramatically reduced by the insertion of a vaginal pessary (cerclage pessary, CE0482, MED/CERT ISO 9003 / EN 46003).
This will be a multicenter trial in the UK and other countries. During routine ultrasound scan at 20-24 weeks of gestation for examination of fetal anatomy and growth, all women with twin pregnancy or with singleton pregnancy found to have a cervix of <25 mm in length and where the fetuses are found to be alive with no major abnormalities, severe twin to twin transfusion syndrome or severe fetal growth restriction in one of the fetuses (in the case of twin pregnancy), will be invited to participate in a randomized trial of standard management vs vaginal insertion of a cerclage pessary. For singleton pregnancy, in both arms the patients with cervical length <15 mm will be given prophylactic progesterone (200 mg vaginal capsule per night up to 34 weeks). Randomization and insertion of the pessary (in those allocated to this group) will be carried out within 5 days after the 20-24 weeks scan.
The pessary will be removed by a simple vaginal examination at 37 weeks or earlier before medically indicated preterm induction of labor or elective cesarean section. The pessary will also be removed in women in preterm labor not responding to tocolytic therapy. In monochorionic twins some obstetricians advise that delivery is carried out at around 36 weeks.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Birth
Keywords
Twins, Short cervix, Preterm birth, Vaginal pessary
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
2109 (Actual)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
No Intervention
Arm Description
Expectant management in twin pregnancy
Arm Title
B
Arm Type
Experimental
Arm Description
Vaginal pessary treatment in twin pregnancy
Arm Title
C
Arm Type
No Intervention
Arm Description
Expectant management in singleton pregnancy with short cervix; Women with cervix <15 mm will be commenced on vaginal progesterone
Arm Title
D
Arm Type
Experimental
Arm Description
Vaginal pessary treatment in singleton pregnancy with short cervix; Women with cervix <15 mm will be commenced on vaginal progesterone
Intervention Type
Device
Intervention Name(s)
Vaginal pessary (CE0482, MED/CERT ISO 9003 / EN 46003)
Other Intervention Name(s)
Vaginal pessary, CE0482, MED/CERT ISO 9003 / EN 46003
Intervention Description
Inserted from randomization till 36-37 weeks of gestation
Primary Outcome Measure Information:
Title
The primary outcome measure will be spontaneous delivery from randomization to 33 weeks and 6 days (237 days) of gestation.
Time Frame
10 weeks
Secondary Outcome Measure Information:
Title
Low birth weight; Fetal or neonatal death; Major adverse outcomes (IVH, RDS, retinopathy of prematurity or necrotizing enterocolitis); Need for neonatal special care (ventilation, phototherapy, treatment for sepsis, blood transfusion)
Time Frame
Within the first year
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Women with singleton pregnancies and with a cervical length of 25 mm or less
Women with twin pregnancies
Exclusion Criteria:
Major fetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery), fetal death, severe twin to twin transfusion syndrome or severe fetal growth restriction in one of the fetuses (in the case of twin pregnancy) diagnosed before randomization.
Painful regular uterine contractions, history of ruptured membranes, or prophylactic cerclage before randomization.
Patients who are unconscious, severely ill, mentally handicapped or under the age of 16 years.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kypros H Nicolaides, Professor
Organizational Affiliation
Consultant,Director of the Department of Fetal Medicine
Official's Role
Study Director
Facility Information:
Facility Name
Medical University of Vienna-department of Obstetrics and Gynaecology
City
Vienna
ZIP/Postal Code
1090
Country
Austria
Facility Name
Universidade Federal Fluminense - Hospital Universitário Antônio Pedro
City
Niteroi
State/Province
Rio De Janeiro
ZIP/Postal Code
24033-900
Country
Brazil
Facility Name
University of Campinas
City
Sao Paulo
Country
Brazil
Facility Name
Hospital Clinico Universidad de Chile
City
Santiago
Country
Chile
Facility Name
Hospital San Jose
City
Bogota
Country
Colombia
Facility Name
Hospital Universitario San Vicente de Paúl
City
Medellin
Country
Colombia
Facility Name
Virchow Clinic Charite
City
Berlin
Country
Germany
Facility Name
Chinese University of Hong Kong
City
Hong Kong
Country
Hong Kong
Facility Name
Fernandez Hospital, Bogulkunta,
City
Bogulkunta
ZIP/Postal Code
500001
Country
India
Facility Name
Ospedale Valduce
City
Como
State/Province
Lombardy
ZIP/Postal Code
22100
Country
Italy
Facility Name
Maternidade Dr. Alfredo da Costa
City
Lisbon
Country
Portugal
Facility Name
Hospital San Teotonio
City
Viseu
Country
Portugal
Facility Name
University Medical Centre Ljubljana
City
Ljubljana
Country
Slovenia
Facility Name
Hospital Universitario Materno Infantil de Canarias
City
Las Palmas de Gran Canaria
State/Province
Islas Canarias
ZIP/Postal Code
35016
Country
Spain
Facility Name
Hospital Universitario Virgen de las Nieves
City
Granada
ZIP/Postal Code
18014
Country
Spain
Facility Name
Virgen de La Arrixaca
City
Murcia
Country
Spain
Facility Name
Heatherwood and Wexham Park Hospitals, Wexham Park Hospital
City
Slough
State/Province
Berkshire
ZIP/Postal Code
SL2 4HL
Country
United Kingdom
Facility Name
Barking, Havering and Redbridge Hospitals NHS Trust
City
Romford
State/Province
Essex
ZIP/Postal Code
RM7 0AG
Country
United Kingdom
Facility Name
Southend Hospital NHS Trust
City
Essex
ZIP/Postal Code
SS0 0RY
Country
United Kingdom
Facility Name
The Medway Maritime Hospital NHS Trust
City
Kent
ZIP/Postal Code
ME7 5NY
Country
United Kingdom
Facility Name
University College London Hospitals NHS Foundation Trust
City
London
ZIP/Postal Code
NW1 2BU
Country
United Kingdom
Facility Name
The Lewisham Hospital NHS Trust
City
London
ZIP/Postal Code
SE13 6LH
Country
United Kingdom
Facility Name
Queen Elizabeth Hospital NHS Trust
City
London
ZIP/Postal Code
SE18 4QH
Country
United Kingdom
Facility Name
King's College Hospital NHS Trust
City
London
ZIP/Postal Code
SE5 9RS
Country
United Kingdom
12. IPD Sharing Statement
Links:
URL
https://fetalmedicine.org/research/randomized-trials/cervical-pessary-for-prevention-of-preterm-birth
Description
Click here for more information about this study: Randomized study of pessary vs standard management in women with increased chance of premature birth
Learn more about this trial
Randomized Study of Pessary Versus Standard Management in Women With Increased Chance of Premature Birth
We'll reach out to this number within 24 hrs